These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 6924817)

  • 21. Methods for determination of prekallikrein in plasma, glandular kallikrein and urokinase.
    Claeson G; Friberger P; Knös M; Eriksson E
    Haemostasis; 1978; 7(2-3):76-8. PubMed ID: 26629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma prekallikrein, factor XII, antithrombin III, C1(-)-inhibitor and alpha 2-macroglobulin in critically ill patients with suspected disseminated intravascular coagulation (DIC).
    Lämmle B; Tran TH; Ritz R; Duckert F
    Am J Clin Pathol; 1984 Oct; 82(4):396-404. PubMed ID: 6206713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assay of total factor XII and of activated factor XII in plasma with a chromogenic substrate.
    Vinazzer H
    Thromb Res; 1979 Jan; 14(1):155-66. PubMed ID: 425078
    [No Abstract]   [Full Text] [Related]  

  • 24. Studies on assays for plasma prekallikrein and for the monitoring of coumarol therapy.
    Egberg N; Bergström K
    Haemostasis; 1978; 7(2-3):85-91. PubMed ID: 149049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of Hageman factor (HG, factor XII) and plasma prekallikrein (Fletcher factor) by radioimmunoassays.
    Saito H
    Adv Exp Med Biol; 1979; 120A():165-72. PubMed ID: 573961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factor XII assay with the chromogenic substrate chromozym PK.
    Dick W; Cullmann W; Müller N; Adler K
    J Clin Chem Clin Biochem; 1981 Jun; 19(6):357-61. PubMed ID: 6168728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chromogenic peptide substrate assays in patients with multiple trauma.
    Kierulf P; Aasen AO; Aune S; Godal HC; Ruud TE; Vaage J
    Acta Chir Scand Suppl; 1982; 509():69-72. PubMed ID: 6962622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The use of a tripeptide chromogenic substrate for simultaneous determination of 4 indices of kallikrein-kinin system].
    Dotsenko VL; Iarovaia GA; Neshkova EA
    Vopr Med Khim; 1989; 35(2):128-33. PubMed ID: 2741408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Factor XII deficiency - Hageman trait. Additional diagnostic procedures].
    Martinić P
    Bilt Hematol Transfuz; 1979; 7(2-3):151-8. PubMed ID: 263755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between kallikrein release and factor XII in normal persons and carriers of the Hageman trait.
    Torres M; Ercoreca L; Lucia JF; Giralt M; Raichs A
    Thromb Haemost; 1979 Dec; 42(4):1286-8. PubMed ID: 261563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of factor XII in plasma using the kallikrein substrate chromozym PK.
    Klessen C; Stürzebecher J; Markwardt F
    Thromb Res; 1982 Mar; 25(6):501-5. PubMed ID: 6921902
    [No Abstract]   [Full Text] [Related]  

  • 32. Analyses of factor XII, prekallikrein and kallikrein inhibitory capacity in patients with laboratory signs of DIC.
    Egberg N; Hellgren M
    Scand J Clin Lab Invest Suppl; 1985; 178():25-9. PubMed ID: 3867118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma prekallikrein activity in patients with total hip arthroplasty.
    Hoffmann JJ; Kortmann JH
    Thromb Haemost; 1987 Dec; 58(4):1040-2. PubMed ID: 3445224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the clotting defect in a factor XII-deficient kindred.
    Chistolini A; Mazzucconi MG; Motta M; Solinas S; Tirindelli MC; Mariani G
    Ric Clin Lab; 1985; 15(3):241-5. PubMed ID: 3853270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An optimized assay for prekallikrein activator activity in human plasma products.
    Tölö H; Suomela H
    Thromb Res; 1982 Jul; 27(1):35-44. PubMed ID: 6981866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High prekallikrein levels during pregnancy.
    Marcel GA; Caspar C; Sabatier C; Gautray J; Schirar A
    Pathol Biol (Paris); 1975 Dec; 23 suppl():66-8. PubMed ID: 772561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kallikrein and prekallikrein levels in a large number of congenital clotting deficiencies and abnormalities.
    Patrassi GM; Martinelli S; Vianello C; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(4):644-54. PubMed ID: 6184289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simple chromogenic peptide substrate assays for determining prekallikrein, kallikrein inhibition and kallikrein "like" activity in human plasma.
    Gallimore MJ; Friberger P
    Thromb Res; 1982 Feb; 25(3):293-8. PubMed ID: 6917564
    [No Abstract]   [Full Text] [Related]  

  • 39. Formation of an association between factor XII and kallikrein in human plasma--significance of storage of plasma and the functional state of plasma kallikrein.
    Hoem NO; Johannesen S; Briseid K
    Thromb Res; 1992 May; 66(4):421-34. PubMed ID: 1412207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prekallikrein deficiency in a family of miniature horses.
    Turrentine MA; Sculley PW; Green EM; Johnson GS
    Am J Vet Res; 1986 Nov; 47(11):2464-7. PubMed ID: 3641551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.